We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+53.66%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$698M
Cap. Flow
+$418M
Cap. Flow %
28.92%
Top 10 Hldgs %
21.33%
Holding
759
New
418
Increased
75
Reduced
55
Closed
163

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16.2M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$4.48M
3
ZM icon
Zoom
ZM
+$3.15M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$2.84M
5
LYFT icon
Lyft
LYFT
+$2.67M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.12%
2 Healthcare 2.1%
3 Technology 1.03%
4 Industrials 0.75%
5 Financials 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
301
Apple
AAPL
$4.97T
$912K 0.06%
+10,000
New +$775K
NCLH icon
302
CALL
Norwegian Cruise Line
NCLH
$9.53B
$904K 0.06%
55,000
+50,000
+1,000% +$733K
PS
303
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$903K 0.06%
50,000
+45,600
+1,036% +$772K
ESPR
304
PUT
DELISTED
Esperion Therapeutics
ESPR
$898K 0.06%
17,500
+2,500
+17% +$105K
ITCI
305
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$898K 0.06%
+35,000
New +$709K
SPG icon
306
CALL
Simon Property Group
SPG
$76.4B
$889K 0.06%
+13,000
New +$815K
PTON icon
307
Peloton Interactive
PTON
$2.85B
$867K 0.06%
+15,000
New +$621K
KTOS icon
308
Kratos Defense & Security Solutions
KTOS
$8.23B
$860K 0.06%
+55,000
New +$880K
FAST icon
309
CALL
Fastenal
FAST
$54.8B
$857K 0.06%
40,000
MRTX
310
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$856K 0.06%
7,500
+2,000
+36% +$194K
YETI icon
311
CALL
Yeti Holdings
YETI
$3.87B
$855K 0.06%
+20,000
New +$601K
KO icon
312
CALL
Coca-Cola
KO
$383B
$849K 0.06%
19,000
-16,000
-46% -$737K
DAL icon
313
PUT
Delta Air Lines
DAL
$56.7B
$842K 0.06%
30,000
BCE icon
314
PUT
BCE
BCE
$20.8B
$835K 0.06%
+20,000
New +$823K
SEDG icon
315
CALL
SolarEdge
SEDG
$2.37B
$833K 0.06%
+6,000
New +$734K
SEDG icon
316
PUT
SolarEdge
SEDG
$2.37B
$833K 0.06%
+6,000
New +$734K
EWJ icon
317
iShares MSCI Japan ETF
EWJ
$21.2B
$824K 0.06%
+15,000
New +$796K
ASB icon
318
CALL
Associated Banc-Corp
ASB
$5.8B
$821K 0.06%
60,000
SYY icon
319
CALL
Sysco
SYY
$40.8B
$820K 0.06%
+15,000
New +$789K
OXY icon
320
PUT
Occidental Petroleum
OXY
$55.7B
$816K 0.06%
44,600
+44,400
+22,200% +$699K
IQ icon
321
CALL
iQIYI
IQ
$1.19B
$812K 0.06%
+35,000
New +$649K
SRPT icon
322
PUT
Sarepta Therapeutics
SRPT
$1.64B
$802K 0.06%
+5,000
New +$680K
CRBP icon
323
CALL
Corbus Pharmaceuticals
CRBP
$165M
$797K 0.06%
3,167
-163
-5% -$32.9K
WBT
324
CALL
DELISTED
Welbilt, Inc.
WBT
$796K 0.06%
+130,700
New +$707K
GO icon
325
PUT
Grocery Outlet
GO
$904M
$779K 0.05%
19,100

Similar funds

SG3 Management's Q2 2020 Portfolio in Review

As of Q2 2020, SG3 Management held 759 positions worth $1.45B, up 93% from $748M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management deployed $418M of net new capital in Q2 2020, opening 418 new positions and adding to 75 existing holdings. Its largest new stake was Sea Limited: 183,000 shares worth $19.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.1% of assets, up from 2% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.21M trimmed.

  • SG3 Management's largest Q2 2020 buy was Sea Limited: 183,000 shares worth $19.6M.
  • SG3 Management added most to PENN Entertainment in Q2 2020, an estimated $2.45M increase.
  • SG3 Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.21M.
  • SG3 Management fully exited Tesla in Q2 2020, selling an estimated $16.2M.
  • SG3 Management's ten largest holdings make up 21% of its $1.45B portfolio in Q2 2020.
  • SG3 Management opened 418 new positions and closed 163 in Q2 2020.
  • SG3 Management's portfolio value rose 93% quarter-over-quarter to $1.45B.

Based on SG3 Management's 13F filing for Q2 2020, filed 14 Aug 2020.